Business Units
Pharmaceutical
Products
Contract
Manufacturing
R&D
Our Strategy
Find out about our strategy for continued growth and enhancing our market position.
International
Expansion
At ROVI, we don't believe in borders.
Reach more countries and more people.
To date, thanks to our 22 alliances with international partners, our principal product, Bemiparin, is now present in more than 55 countries.
With our Enoxaparin Biosimilar, we hope to increase our presence in Europe, the United States and emerging countries
Licenses
Our profile and our experience in the Spanish market make us an attractive
licensee for the successful marketing of new products.
Nowadays, we offer product licenses to third parties:
